Prosecution Insights
Last updated: August 18, 2026

Singular Genomics Systems Inc.

17 pending office actions • 9 art units • 17 examiners • 0 of 17 (0%) have an AI response strategy ready • 30 patents granted in the last 365 days

Portfolio Summary

17
Total Pending OAs
12
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (29%)
8
Medium (47%)
4
Easy (24%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only5 (29%)
§112 only3 (18%)
Double-patenting only1 (6%)
Double-patenting + other3 (18%)
Multi-statute (no §101)5 (29%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

17
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

170 h
Manual time on pending OAs
34 h
Time saved (low, 20%)
59 h
Time saved (mid, 35%)
1.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
QIAN, CELINE X 1 47.6% +16.7%
LU, FRANK WEI MIN 1 62.6% +67.6%
HERON, VELVET ELIZABETH 1 46.7% +50.0%
HAQ, SHAFIQUL 1 65.0% +55.1%
SISSON, BRADLEY L 1 19.7% +20.6%
MUMMERT, STEPHANIE KANE 1 60.8% +21.8%
GALSTER, SAMUEL LEONARD 1 52.3% +41.7%
GOLDBERG, JEANINE ANNE 1 45.9% +40.9%
WHATLEY, BENJAMIN R 1 66.7% +68.1%
KAPUSHOC, STEPHEN THOMAS 1 46.7% +53.2%

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17938254 Polynucleotide Barcodes for Multiplexed Proteomics BUNKER, AMY M 4d overdue
18915941 PROXIMITY DETECTION OF BIOMOLECULE INTERACTIONS SISSON, BRADLEY L 13d
19038150 SOLID SUPPORTS USEFUL FOR TISSUE ADHERENCE HERON, VELVET ELIZABETH
18959243 ANALYZING CELL SAMPLES HAQ, SHAFIQUL
18797131 SPATIAL DETECTION OF CLONOTYPES IN TISSUES MUMMERT, STEPHANIE KANE
18339628 SPATIAL DETECTION OF BIOMOLECULE INTERACTIONS VANN-OJUEKAIYE, KENDRA RAYCHELL

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18915941 PROXIMITY DETECTION OF BIOMOLECULE INTERACTIONS SISSON, BRADLEY L 13d
19345390 ENCODING METHODS FOR MULTIPLEXED DETECTION OF TARGETS IN CELLS QIAN, CELINE X
19344246 METHODS FOR THREE-DIMENSIONAL NUCLEIC ACID SEQUENCING LU, FRANK WEI MIN
19038150 SOLID SUPPORTS USEFUL FOR TISSUE ADHERENCE HERON, VELVET ELIZABETH
18959243 ANALYZING CELL SAMPLES HAQ, SHAFIQUL
18797131 SPATIAL DETECTION OF CLONOTYPES IN TISSUES MUMMERT, STEPHANIE KANE
18543979 DISULFIDE CONTAINING THERAPEUTICS GALSTER, SAMUEL LEONARD
18537540 LINKED TRANSCRIPT SEQUENCING GOLDBERG, JEANINE ANNE

Top Art Units

Art UnitApps
1682 6
1683 3
1681 2
1637 1
1798 1
1678 1
1693 1
1699 1
1684 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19345390 ENCODING METHODS FOR MULTIPLEXED DETECTION OF TARGETS IN CELLS QIAN, CELINE X 1637 §112 Final Rejection Pending Sep 30, 2025
19344246 METHODS FOR THREE-DIMENSIONAL NUCLEIC ACID SEQUENCING LU, FRANK WEI MIN 1683 §112 Non-Final OA Pending Sep 29, 2025
19038150 SOLID SUPPORTS USEFUL FOR TISSUE ADHERENCE HERON, VELVET ELIZABETH 1798 §102§103 Non-Final OA Pending Jan 27, 2025
18959243 ANALYZING CELL SAMPLES HAQ, SHAFIQUL 1678 §103§112 Final Rejection Pending Nov 25, 2024
18915941 PROXIMITY DETECTION OF BIOMOLECULE INTERACTIONS SISSON, BRADLEY L 1682 §112 Non-Final OA 13d Pending Oct 15, 2024
18797131 SPATIAL DETECTION OF CLONOTYPES IN TISSUES MUMMERT, STEPHANIE KANE 1681 §102§103 Non-Final OA Pending Aug 07, 2024
18543979 DISULFIDE CONTAINING THERAPEUTICS GALSTER, SAMUEL LEONARD 1693 §103 Non-Final OA Pending Dec 18, 2023
18537540 LINKED TRANSCRIPT SEQUENCING GOLDBERG, JEANINE ANNE 1682 §103DP Non-Final OA Pending Dec 12, 2023
18490491 MULTI-DIMENSIONAL POLYMER SCAFFOLDS FOR NUCLEIC ACID ANALYSES WHATLEY, BENJAMIN R 1699 §102§103§112DP Non-Final OA Pending Oct 19, 2023
18455954 NUCLEIC ACID DELIVERY SCAFFOLDS KAPUSHOC, STEPHEN THOMAS 1683 DP Non-Final OA Pending Aug 25, 2023
18364849 COMPETITIVE METHODS AND COMPOSITIONS FOR AMPLIFYING POLYNUCLEOTIDES TURPIN, ZACHARY MARK 1682 §103 Final Rejection 8d overdue Pending Aug 03, 2023
18357850 METHODS AND COMPOSITIONS FOR AMPLIFYING POLYNUCLEOTIDES POHNERT, STEVEN C 1683 §102§103DP Non-Final OA Pending Jul 24, 2023
18339628 SPATIAL DETECTION OF BIOMOLECULE INTERACTIONS VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 §103§112 Non-Final OA Pending Jun 22, 2023
18069078 PHASE PROTECTIVE REAGENT FLOW ORDERING KENNEDY, SARAH JANE 1682 §103 Final Rejection Pending Dec 20, 2022
18050688 METHODS AND COMPOSITIONS USEFUL FOR NUCLEIC ACID SEQUENCING CROW, ROBERT THOMAS 1682 §103 Non-Final OA 97d overdue Pending Oct 28, 2022
17938254 Polynucleotide Barcodes for Multiplexed Proteomics BUNKER, AMY M 1684 §102§103 Final Rejection 4d overdue Pending Oct 05, 2022
17531488 CONTACTLESS DETECTION OF AN ABERRANT CONDITION YU, TIAN NMN 1681 §103 Non-Final OA Pending Nov 19, 2021

Managing Singular Genomics Systems Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month